CN110628726B - 一种番鸭新型腺病毒株、二价灭活疫苗及其制备方法 - Google Patents
一种番鸭新型腺病毒株、二价灭活疫苗及其制备方法 Download PDFInfo
- Publication number
- CN110628726B CN110628726B CN201910953030.7A CN201910953030A CN110628726B CN 110628726 B CN110628726 B CN 110628726B CN 201910953030 A CN201910953030 A CN 201910953030A CN 110628726 B CN110628726 B CN 110628726B
- Authority
- CN
- China
- Prior art keywords
- virus
- dadv
- muscovy duck
- strain
- duck adenovirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000272834 Cairina moschata Species 0.000 title claims abstract description 84
- 241000701161 unidentified adenovirus Species 0.000 title claims abstract description 33
- 229940031551 inactivated vaccine Drugs 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 241000700605 Viruses Species 0.000 claims abstract description 72
- 241000701109 Human adenovirus 2 Species 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 claims abstract description 18
- 239000000427 antigen Substances 0.000 claims abstract description 5
- 102000036639 antigens Human genes 0.000 claims abstract description 5
- 108091007433 antigens Proteins 0.000 claims abstract description 5
- 230000002779 inactivation Effects 0.000 claims description 9
- 239000002671 adjuvant Substances 0.000 claims description 7
- 230000001804 emulsifying effect Effects 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 4
- 229960000380 propiolactone Drugs 0.000 claims description 4
- 230000000415 inactivating effect Effects 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000000108 ultra-filtration Methods 0.000 claims description 3
- 241000272525 Anas platyrhynchos Species 0.000 abstract description 25
- 229960005486 vaccine Drugs 0.000 abstract description 24
- 241000193096 Human adenovirus B3 Species 0.000 abstract description 14
- 238000012360 testing method Methods 0.000 abstract description 12
- 238000011161 development Methods 0.000 abstract description 5
- 206010067484 Adverse reaction Diseases 0.000 abstract description 3
- 230000006838 adverse reaction Effects 0.000 abstract description 3
- 238000004458 analytical method Methods 0.000 abstract description 3
- 230000001900 immune effect Effects 0.000 abstract description 3
- 230000014759 maintenance of location Effects 0.000 abstract description 3
- 238000011076 safety test Methods 0.000 abstract description 3
- 230000009885 systemic effect Effects 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 22
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000003053 immunization Effects 0.000 description 9
- 238000002649 immunization Methods 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 210000001161 mammalian embryo Anatomy 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 210000002257 embryonic structure Anatomy 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 238000003306 harvesting Methods 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 244000144977 poultry Species 0.000 description 4
- 238000010257 thawing Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 241000886675 Duck atadenovirus A Species 0.000 description 3
- 238000011888 autopsy Methods 0.000 description 3
- 241000701792 avian adenovirus Species 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 230000000120 cytopathologic effect Effects 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000008055 phosphate buffer solution Substances 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 241000886677 Duck adenovirus 1 Species 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 101710094396 Hexon protein Proteins 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000012888 bovine serum Substances 0.000 description 2
- 210000003837 chick embryo Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000012447 hatching Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000008774 maternal effect Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000272522 Anas Species 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000770684 Duck adenovirus 2 Species 0.000 description 1
- 206010015856 Extrasystoles Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000701149 Human adenovirus 1 Species 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000526754 Pannonibacter phragmitetus Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 206010052535 Small intestinal haemorrhage Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940031416 bivalent vaccine Drugs 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 208000026555 breast adenosis Diseases 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 210000003711 chorioallantoic membrane Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011841 epidemiological investigation Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 230000000951 immunodiffusion Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000030175 lameness Diseases 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000011265 semifinished product Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10211—Aviadenovirus, e.g. fowl adenovirus A
- C12N2710/10221—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10211—Aviadenovirus, e.g. fowl adenovirus A
- C12N2710/10234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910953030.7A CN110628726B (zh) | 2019-09-30 | 2019-09-30 | 一种番鸭新型腺病毒株、二价灭活疫苗及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910953030.7A CN110628726B (zh) | 2019-09-30 | 2019-09-30 | 一种番鸭新型腺病毒株、二价灭活疫苗及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110628726A CN110628726A (zh) | 2019-12-31 |
CN110628726B true CN110628726B (zh) | 2021-08-06 |
Family
ID=68976034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910953030.7A Active CN110628726B (zh) | 2019-09-30 | 2019-09-30 | 一种番鸭新型腺病毒株、二价灭活疫苗及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110628726B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111166875A (zh) * | 2020-01-08 | 2020-05-19 | 广州恩宝生物医药科技有限公司 | 一种腺病毒二价疫苗 |
CN113198011B (zh) * | 2021-04-28 | 2023-05-09 | 重庆永健生物技术有限责任公司 | 一种鸭腺病毒3型菌株灭活疫苗及其应用 |
CN114209821A (zh) * | 2021-12-30 | 2022-03-22 | 哈药集团生物疫苗有限公司 | 防治鸭圆环病毒病、新型鸭呼肠孤病毒病和鸭腺病毒病3型的三联灭活疫苗及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107137704B (zh) * | 2016-08-20 | 2020-02-21 | 山东信得科技股份有限公司 | 一种鸭2型腺病毒灭活疫苗 |
CN108465107B (zh) * | 2018-06-05 | 2020-02-21 | 山东信得科技股份有限公司 | 一种鸭2型腺病毒和番鸭细小病毒病二联灭活疫苗 |
CN108939063B (zh) * | 2018-06-05 | 2022-06-03 | 山东信得科技股份有限公司 | 一种番鸭三联灭活疫苗 |
CN108956987B (zh) * | 2018-06-15 | 2021-08-27 | 新兴县国研科技有限公司 | fiber2蛋白及其重组蛋白在检测鸭血清中鸭2型腺病毒抗体方面的应用 |
CN108913813B (zh) * | 2018-07-23 | 2022-04-12 | 福建省农业科学院畜牧兽医研究所 | 用于鉴别DAdV-2和DAdV-3的引物组 |
CN110117576B (zh) * | 2019-04-23 | 2023-02-10 | 广东迈科特生物科技有限公司 | 一种鸭腺病毒3型病毒株及其卵黄抗体制备和应用 |
-
2019
- 2019-09-30 CN CN201910953030.7A patent/CN110628726B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN110628726A (zh) | 2019-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110628726B (zh) | 一种番鸭新型腺病毒株、二价灭活疫苗及其制备方法 | |
CN109082415B (zh) | 一种鹅星状病毒病毒株及其应用 | |
CN107137704B (zh) | 一种鸭2型腺病毒灭活疫苗 | |
CN111905100B (zh) | 一种鹅星状病毒二价灭活疫苗和卵黄抗体及其制备方法 | |
CN111000993B (zh) | 一种鸭病毒性肝炎、鸭呼肠孤病毒病二联灭活疫苗及其制备方法 | |
CN104922663A (zh) | 一种鸡新城疫和h9亚型禽流感二联疫苗 | |
CN106754754B (zh) | 一种禽腺病毒ⅰ群4型毒株wz株及其应用 | |
CN105582533B (zh) | 一种禽流感病毒、禽腺病毒二联灭活疫苗 | |
CN109265540B (zh) | 一种鹅星状病毒卵黄抗体的制备及其应用 | |
CN105949307B (zh) | 一种用于防治番鸭源小鹅瘟的卵黄抗体 | |
CN105664150B (zh) | 一种鸡新城疫病毒、禽流感病毒和禽腺病毒三联灭活疫苗 | |
CN108465107B (zh) | 一种鸭2型腺病毒和番鸭细小病毒病二联灭活疫苗 | |
CN105535958B (zh) | 一种鸡新城疫病毒、传染性支气管炎、禽腺病毒三联灭活疫苗 | |
CN104548088A (zh) | 一种鸡新城疫病毒La Sota株和鸡传染性支气管炎病毒N-S多表位蛋白二联疫苗制备方法 | |
CN110564699B (zh) | 一种新型番鸭腺病毒株、灭活疫苗及其制备方法 | |
CN109097340A (zh) | 一种禽腺病毒、一种四联疫苗及其制备方法 | |
CN109207436A (zh) | 一株i群4型禽腺病毒毒株及其应用 | |
CN108939063B (zh) | 一种番鸭三联灭活疫苗 | |
CN102965344B (zh) | 用细胞系生产鸡传染性支气管炎病毒与疫苗 | |
CN109055320B (zh) | 一株传染性支气管炎病毒分离株及在疫苗制备中的应用 | |
CN106563125A (zh) | 鸭甲肝病毒ⅲ型复合物活疫苗及其制备方法 | |
CN106854647A (zh) | 鸭病毒性肝炎二价蛋黄抗体及其制备方法和应用 | |
CN109260467B (zh) | 一种预防雏鹅痛风症状的疫苗 | |
CN112999343B (zh) | 一种鹅星状病毒的灭活疫苗及其制备方法 | |
CN111110839B (zh) | 一种预防雏鹅痛风的鹅星状病毒二价灭活疫苗 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Novel Muscovy Duck adenovirus strain, bivalent inactivated vaccine and preparation method thereof Effective date of registration: 20211222 Granted publication date: 20210806 Pledgee: Shandong Zhucheng rural commercial bank Limited by Share Ltd. Pledgor: SHANDONG SINDER TECHNOLOGY Co.,Ltd. Registration number: Y2021980015708 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20221223 Granted publication date: 20210806 Pledgee: Shandong Zhucheng rural commercial bank Limited by Share Ltd. Pledgor: SHANDONG SINDER TECHNOLOGY Co.,Ltd. Registration number: Y2021980015708 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A new adenovirus strain, bivalent Inactivated vaccine of muscovy duck and its preparation method Effective date of registration: 20230608 Granted publication date: 20210806 Pledgee: Shandong Zhucheng rural commercial bank Limited by Share Ltd. Pledgor: SHANDONG SINDER TECHNOLOGY Co.,Ltd. Registration number: Y2023980043376 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20210806 Pledgee: Shandong Zhucheng rural commercial bank Limited by Share Ltd. Pledgor: SHANDONG SINDER TECHNOLOGY Co.,Ltd. Registration number: Y2023980043376 |